Product Launch Announcement: Letroclear 2.5 (Letrozole 2.5mg) Tablet
We are proud to introduce Letroclear 2.5 tablets, a hormonal anticancer therapy containing Letrozole 2.5mg, designed to reduce estrogen production and help manage hormone-sensitive breast cancer. It is an established treatment option for postmenopausal women with hormone receptor-positive breast cancer, offering targeted action through aromatase inhibition.
🔍 Product Overview
Generic Name: Letrozole
Strength: 2.5mg
Formulation: Tablets
Primary Indications:
Letroclear 2.5 – Letrozole 2.5mg Tablet is indicated for the treatment of:
- Hormone receptor-positive early breast cancer in postmenopausal women (adjuvant treatment).
- Extended adjuvant treatment of early breast cancer following standard tamoxifen therapy.
- Advanced or metastatic breast cancer in postmenopausal women with hormone receptor-positive or hormone receptor-unknown disease.
- Advanced breast cancer progressing after anti-estrogen therapy, as prescribed.
Mechanism of Action
Letrozole is a non-steroidal aromatase inhibitor that selectively blocks the aromatase enzyme responsible for converting androgens into estrogens.
By inhibiting this enzyme, Letroclear 2.5 significantly reduces estrogen production in the body. This helps suppress estrogen-dependent stimulation of breast cancer cells and supports the management of hormone-sensitive breast cancer.
💡 Key Benefits
- Selective aromatase inhibition for effective estrogen suppression.
- Helps reduce estrogen levels in postmenopausal women.
- Supports hormonal management of hormone receptor-positive breast cancer.
- Established therapeutic option in adjuvant and advanced breast cancer treatment.
- Convenient once-daily oral tablet formulation.
- Supports long-term hormonal therapy under medical supervision.
🎯 Target Audience
- Medical Oncologists and Surgical Oncologists
- Gynaecologists and Cancer Specialists
- Hospitals and Oncology Treatment Centres
- Specialty Pharmacies and Pharmaceutical Distributors
- Healthcare Professionals involved in breast cancer management
🏥 Commitment to Clinical Excellence
Letroclear 2.5 represents our commitment to providing quality pharmaceutical solutions that support established cancer treatment protocols. We strive to maintain high standards of product quality, safety, consistency, and reliability, reinforcing confidence among healthcare professionals.
📦 Availability
Letroclear 2.5 – Letrozole 2.5mg Tablets are available through authorized pharmaceutical distributors. For ordering, partnerships, or regulatory information, please contact the marketing authorization holder.
